0001127602-18-016408.txt : 20180504
0001127602-18-016408.hdr.sgml : 20180504
20180504175557
ACCESSION NUMBER: 0001127602-18-016408
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180503
FILED AS OF DATE: 20180504
DATE AS OF CHANGE: 20180504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPA JOSEPH C
CENTRAL INDEX KEY: 0001242215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 18809196
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMACEUTICALS INC
STREET 2: 311 BONNIE CIRCLE
CITY: CORONA
STATE: CA
ZIP: 92880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-05-03
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001242215
PAPA JOSEPH C
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
1
CHAIRMAN & CEO
Common Shares, No Par Value
2018-05-03
4
F
0
91942
18.31
D
627077
D
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
/s/ Kirsten O'Donnell, attorney-in-fact for Joseph C. Papa
2018-05-04